CRH (NYSE: CRH), a leading provider of building materials solutions, today reported fourth quarter and full year 2024 financial results. Key Highlights Summary Financials Q4 2024 Change FY 2024 Change…
read moreNEW YORK – February 13, 2025 – CRH (NYSE: CRH), the leading provider of building materials solutions, will publish its fourth quarter and full year 2024 financial results after the…
read moreCRH plc issues Q3 2024 Results for the three months ended September 30, 2024. Key Highlights Summary Financials Q3 2024 Change Q3 YTD 2024 Change Total revenues $10.5bn +4% $26.7bn…
read moreNEW YORK – October 30, 2024 – CRH plc (NYSE: CRH), the leading provider of building materials solutions, will publish its Q3 2024 financial results on Thursday, November 7, 2024…
read moreCRH plc issues Q2 2024 Results for the three months ended June 30, 2024. Key Highlights Summary Financials Q2 2024 Change H1 2024 Change Total revenues $9.7bn -1% $16.2bn –…
read moreNEW YORK – July 25, 2024 – CRH plc (NYSE: CRH), the leading provider of building materials solutions, will publish its Q2 2024 financial results on Thursday, August 8, 2024…
read moreCRH plc issues Q1 2024 Results for the three months ended 31 March 2024. Key Highlights Summary Financials Q1 2024 Change Total revenues $6.5bn +2% Net income $114m n/m1 Net…
read moreCRH plc, the leading provider of building materials solutions, will publish its Q1 2024 financial results on Friday, May 10, 2024 at 2:00 a.m. (New York) / 7:00 a.m. (Dublin)…
read moreCRH plc issues Full Year Results for the year ended 31 December 2023. Key Highlights Summary Financials (U.S. GAAP) 2023 Change Total revenues $34.9bn +7% Income from continuing operations $3.1bn…
read moreCRH plc, the leading provider of building materials solutions, will publish its full year 2023 financial results on Thursday, February 29, 2024 at 2:00am ET (7:00am GMT) followed by a…
read moreCRH plc, the leader in building materials solutions, issues the following Interim Results for the six months ended 30 June 2023. Key Highlights Strong H1 delivery; further growth across all…
read more